We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.
An @FDA advisory committee found the benefits of a Truqap combo for advanced prostate cancer outweighed risks. Committee member Kyle Robinson, MD, said doctors have grown accustomed to cross-specialty collabs to address toxicity concerns. @OncNewsCentralspr.ly/6012B8ZPZA
Pulsed field ablation (PFA) is redefining AFib treatment—offering myocardial selectivity with near zero risk of collateral injury and promising clinical outcomes. Learn more about this #Afib treatment technique. spr.ly/6018B8m7gK
From acute stabilization to chronic management, AortaDelphia 2026 underscored integrated care models, patient education, and innovation shaping the future of aortic disease management. spr.ly/6015B8FnSD
Aortic dissection care doesn’t end after surgery. From acute stabilization to lifelong surveillance, managing aortic dissection is a continuum—not a one-time intervention. Learn how aortic management evolves from emergent care to lifelong monitoring.
spr.ly/6015B8brCF
Big strides in solid tumor cancer care at @PennMedicine—bringing groundbreaking cell therapies like lifileucel to patients with melanoma and rare sarcomas. A glimpse at how innovation is turning breakthroughs into real treatment options. spr.ly/6019B8k8Mz
Led by Dr. Elizabeth McDonald (@PennRadiology/@PennCancer), the retrospective study of 110k women is also published in @JCO_ASCO. While observational, the findings pave the way for a multisite clinical trial to investigate GLP-1s as a breast cancer prevention tool.
‼️ #ASCO26 simultaneous publication by @McDonald et al:
GLP-1 agonists are associated with a significant reduction in breast cancer incidence in women
Read the full article: ascopubs.org/doi/abs/10.1200…#bcsm
As AFib prevalence rises, early rhythm control is critical. Pulsed field ablation shows strong efficacy and an improved safety profile vs. thermal techniques. #AFib#Cardiologyspr.ly/6012B8m76r
Improving outcomes in gynecologic oncology means improving access to care. Expanding regional care, reducing barriers, and increasing trial participation are key steps toward more equitable cancer care. spr.ly/6017B8nA6t
In an update to his presentation from last year, @StephenBagleyMD presented new data from a phase 1 trial that used CAR T cell therapy in glioblastoma patients at #ASCO26.
#ASCO26 isn’t just about networking for our clinicians and scientists. We are dedicated to learning and growing to provide better care for our patients—because they deserve it.
A short in-person #ASCO26 for me but leaving feeling energized and inspired about the future of #oncology, #hematology, and #meded!
Looking forward to joining in the fun remotely, especially tomorrow’s session on AI, which includes our project presented by @GarradEvan!
As AI becomes more integrated into cancer care, patients are turning online to understand how it impacts diagnosis, treatment, and research. But are those resources meeting patients’ needs? @PennCancer@ASCO@PennMDForum🧵
Read more: pennmedicine.org/news/major-…
Led by senior author Henry Litt, MD & presented by Pearl Subramanian, MD at #ASCO26, the research shows: health systems and cancer centers have an opportunity to create more accessible, patient-friendly resources that are readable, trustworthy, and transparent about safety.
Proud of @TejaVorugantiMD for leading efforts in #YoungLung Cancer @PennMedicine@PennCancer - he is presenting today on patterns, demographic, biological and tx factors. Including a shout out from EO/AYA Research Group Shoutout!
#ASCO26